Expert-level detection of low-voltage intervals in EEG as a robust biomarker of neonatal encephalopathy
Organizations: CergenX Ltd, Cork, Ireland · INFANT Research Centre, University College Cork, Ireland · Department of Paediatrics and Child Health, University College Cork, Ireland
Abstract
Background: Discontinuity in neonatal EEG is a critical marker of brain dysfunction but can be difficult to quantify visually. Inter-burst intervals (IBIs) are a key characteristic of discontinuity, yet their definition does not easily translate to AI detection. Objectives: To introduce low-voltage intervals (LVIs), defined exclusively by amplitude and duration, as a context-independent alternative to IBIs, develop an AI detection method for LVIs, and assess their clinical utility as a marker of brain injury. Methods: We developed a ConvNeXt model to detect LVIs and compared its performance with existing methods. We then tested the clinical relevance of detected LVIs across four applications: 1) grading background EEG abnormalities on an open benchmark dataset, 2) classifying clinical hypoxic-ischaemic encephalopathy (HIE) grades and comparing with a normal EEG dataset, 3) seizure prediction, and 4) association with seizure burden. Results: For training and validation, 654 hours of per-channel EEG from 123 neonates were reviewed and 51,162 LVIs were annotated. On held-out validation, ConvNeXt had an AUC of 0.996 and a Matthews correlation coefficient of 0.926. Model-reader agreement exceeded inter-reader agreement (, 95% CI: 0.007 to 0.045, ), attaining expert-level equivalence. On a combined dataset of 444 neonates, percentage LVI showed a strong association with EEG grades (Spearman's ), a moderate association with HIE grades (), a weaker association with seizure burden (), and a strong seizure prediction capacity (AUC ). Conclusion: AI detection of LVIs achieves expert-level equivalence, whereas quantitative features do not. Automated LVI quantification provides a robust clinical biomarker of neonatal encephalopathy associated with background EEG activity, HIE severity, and seizure risk.
Figures & tables
| development set | validation set | |
| (n=51) | (n=72) | |
| Gestational Age (weeks) | 40+2 (39+2 – 40+5) | 39+6 (39+0 – 40+5) |
| Birth Weight (kg) | 3.5 (3.33 – 3.85) [n=26] | 3.64 (3.37 – 3.83) [n=23] |
| Sex, Female | 18 (35.3%) | 28 (38.9%) |
| HIE | 26 (51.0%) | 55 (76.3%) |
| HIE: Mild / Moderate / Severe | 9 / 13 / 4 | 26 / 18 / 11 |
Appendix figures & tables11 assets
Supplementary material from the paper’s appendix.
Appendix
| application set | |
| ( ) | |
| Gestational Age (weeks) | 40+0 (39+1 – 41+0) [ ] |
| Birth Weight (kg) | 3.5 (3.14 – 3.79) [ ] |
| Sex, Female | 138 (43.4%) [ ] |
| HIE | 222 (56.8%) |
| HIE: Mild / Moderate / Severe / Unknown | 96 / 94 / 31 / 1 |
| Dataset | Reviewer | Number of | Prevalence | Duration (seconds) |
| Events | median (IQR) | |||
| Development | R1 | 36,580 | 0.202 | 5.48 (3.55–9.31) |
| Validation | R2 | 5,845 | 0.306 | 4.59 (2.94–9.19) |
| Validation | R3 | 8,737 | 0.299 | 3.20 (2.36–6.06) |
| AUC | AP | accuracy | MCC | sens./spec. | PPV/NPV | |||
| (%) | (%) | (%) | ||||||
| ConvNeXt | 0.996 | 0.943 | 0.992 | 96.9 | 0.926 | 0.926 | 95.9 / 97.4 | 93.7 / 98.3 |
| SVM | 0.996 | 0.895 | 0.990 | 96.8 | 0.923 | 0.923 | 94.4 / 97.8 | 94.6 / 97.7 |
| Peak-to-peak | 0.983 | 0.673 | 0.943 | 93.0 | 0.845 | 0.838 | 97.5 / 91.1 | 81.8 / 98.9 |
| EDO | 0.988 | 0.014 | 0.971 | 91.1 | 0.813 | 0.800 | 97.9 / 88.4 | 77.5 / 99.0 |
| Envelope | 0.987 | 0.176 | 0.975 | 91.7 | 0.819 | 0.810 | 96.9 / 89.5 | 79.0 / 98.6 |
| AUC | accuracy (%) | MCC | ||
| ConvNeXt | 0.994 | 0.788 | 98.7 | 0.736 |
| (0.987 to 0.998) | (0.652 to 0.867) | (95.7 to 99.6) | (0.629 to 0.849) | |
| SVM | 0.993 | 0.559 | 98.6 | 0.703 |
| (0.985 to 0.996) | (0.335 to 0.750) | (95.2 to 99.6) | (0.556 to 0.812) | |
| Peak-to-peak | 0.955 | 0.319 | 93.8 | 0.470 |
| (0.905 to 0.975) | (0.154 to 0.503) | (90.1 to 97.9) | (0.359 to 0.676) |
| 95% CI | -value | ||
| ConvNeXt | 0.024 | 0.011 to 0.040 | 0.001 |
| SVM | 0.020 | 0.008 to 0.034 | 0.001 |
| Peak-to-peak | -0.049 | -0.073 to -0.025 | 0.774 |
| EDO | -0.081 | -0.104 to -0.058 | 0.999 |
| Envelope | -0.074 | -0.100 to -0.049 | 0.991 |
| Line Length | -0.114 | -0.140 to -0.087 | 0.999 |
| Mean difference | 95% CI | -value | |
| Maximum duration (s) | 0.100 | -0.686 to 0.856 | 0.583 |
| Median duration (s) | 0.172 | -0.188 to 0.594 | 0.777 |
| Percentage (%) | -1.291 | -2.818 to -0.245 | 0.023 |
| Number of events | -24.489 | -34.558 to -11.589 | 0.001 |
| Complexity | -0.036 | -0.068 to -0.019 | 0.001 |
| Periodicity | -0.001 | -0.002 to -0.000 | 0.013 |
| EEG background grades | HIE grades & normal cohort | |||
| feature | effect size | correlation | effect size | correlation |
| ( ) | ( ) | ( ) | ( ) | |
| Maximum duration (s) | 0.521 | 0.714 | 0.269 | 0.311 |
| Median duration (s) | 0.676 | 0.821 | 0.248 | 0.349 |
| Percent (%) | 0.643 | 0.801 | 0.297 | 0.384 |
| Number | 0.523 | 0.630 | 0.164 | 0.250 |
| Seizure prediction | Association with seizure burden | |||
| feature | AUC | correlation | effect size | correlation |
| ( ) | ( ) | ( ) | ||
| Maximum duration (s) | ||||
| Median duration (s) | ||||
| Percent (%) | ||||
| Number | ||||
Electroencephalography
Electroencephalography (EEG) studies brain-generated electrical activity to understand cognition and support diagnosis, monitoring, and brain-computer interfaces.
See all 178 papers